These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 15300364)

  • 1. Idiopathic osteoporosis in premenopausal women.
    Rubin MR; Schussheim DH; Kulak CA; Kurland ES; Rosen CJ; Bilezikian JP; Shane E
    Osteoporos Int; 2005 May; 16(5):526-33. PubMed ID: 15300364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density.
    Cohen A; Recker RR; Lappe J; Dempster DW; Cremers S; McMahon DJ; Stein EM; Fleischer J; Rosen CJ; Rogers H; Staron RB; Lemaster J; Shane E
    Osteoporos Int; 2012 Jan; 23(1):171-82. PubMed ID: 21365462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age, body mass index, current smoking history, and serum insulin-like growth factor-I levels associated with bone mineral density in middle-aged Korean men.
    Rhee EJ; Oh KW; Lee WY; Kim SW; Oh ES; Baek KH; Kang MI; Park CY; Choi MG; Yoo HJ; Park SW
    J Bone Miner Metab; 2004; 22(4):392-8. PubMed ID: 15221500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-I in men with idiopathic osteoporosis.
    Kurland ES; Rosen CJ; Cosman F; McMahon D; Chan F; Shane E; Lindsay R; Dempster D; Bilezikian JP
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2799-805. PubMed ID: 9284699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis.
    Lormeau C; Soudan B; d'Herbomez M; Pigny P; Duquesnoy B; Cortet B
    Bone; 2004 Jun; 34(6):933-9. PubMed ID: 15193539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization.
    Colao A; Di Somma C; Loche S; Di Sarno A; Klain M; Pivonello R; Pietrosante M; Salvatore M; Lombardi G
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):319-27. PubMed ID: 10718830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentration of insulin-like growth factor (IGF)-I in iliac crest bone matrix in premenopausal women with idiopathic osteoporosis.
    Pepene CE; Seck T; Diel I; Minne HW; Ziegler R; Pfeilschifter J
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):38-43. PubMed ID: 14758570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal bone microarchitecture and evidence of osteoblast dysfunction in premenopausal women with idiopathic osteoporosis.
    Cohen A; Dempster DW; Recker RR; Stein EM; Lappe JM; Zhou H; Wirth AJ; van Lenthe GH; Kohler T; Zwahlen A; Müller R; Rosen CJ; Cremers S; Nickolas TL; McMahon DJ; Rogers H; Staron RB; LeMaster J; Shane E
    J Clin Endocrinol Metab; 2011 Oct; 96(10):3095-105. PubMed ID: 21832117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF-1 as an early marker for low bone mass or osteoporosis in premenopausal and postmenopausal women.
    Liu JM; Zhao HY; Ning G; Chen Y; Zhang LZ; Sun LH; Zhao YJ; Xu MY; Chen JL
    J Bone Miner Metab; 2008; 26(2):159-64. PubMed ID: 18301972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone density in women receiving depot medroxyprogesterone acetate for contraception.
    Cundy T; Evans M; Roberts H; Wattie D; Ames R; Reid IR
    BMJ; 1991 Jul; 303(6793):13-6. PubMed ID: 1830502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN.
    Sowers MR; Finkelstein JS; Ettinger B; Bondarenko I; Neer RM; Cauley JA; Sherman S; Greendale GA;
    Osteoporos Int; 2003 Jan; 14(1):44-52. PubMed ID: 12577184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex steroids and bone turnover markers in men with symptomatic vertebral fractures.
    Tuck SP; Scane AC; Fraser WD; Diver MJ; Eastell R; Francis RM
    Bone; 2008 Dec; 43(6):999-1005. PubMed ID: 18817902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship among VDR (BsmI and FokI), COLIA1, and CTR polymorphisms with bone mass, bone turnover markers, and sex hormones in men.
    Braga V; Sangalli A; Malerba G; Mottes M; Mirandola S; Gatti D; Rossini M; Zamboni M; Adami S
    Calcif Tissue Int; 2002 Jun; 70(6):457-62. PubMed ID: 12016463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phalangeal quantitative ultrasound technology and dual energy X-ray densitometry in patients with primary hyperparathyroidism: influence of sex and menopausal status.
    Camozzi V; Lumachi F; Mantero F; Piccolo M; Luisetto G
    Osteoporos Int; 2003 Jul; 14(7):602-8. PubMed ID: 12730752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of dietary calcium intake with metabolic syndrome and bone mineral density among the Korean population: KNHANES 2008-2011.
    Kim MK; Chon SJ; Noe EB; Roh YH; Yun BH; Cho S; Choi YS; Lee BS; Seo SK
    Osteoporos Int; 2017 Jan; 28(1):299-308. PubMed ID: 27503170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A potentially deleterious role of IGFBP-2 on bone density in aging men and women.
    Amin S; Riggs BL; Atkinson EJ; Oberg AL; Melton LJ; Khosla S
    J Bone Miner Res; 2004 Jul; 19(7):1075-83. PubMed ID: 15176989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF)-I and IGF-binding protein (IGFBP)-3 in Swedish men.
    Gillberg P; Olofsson H; Mallmin H; Blum WF; Ljunghall S; Nilsson AG
    Calcif Tissue Int; 2002 Jan; 70(1):22-9. PubMed ID: 11907704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor I is a determinant of hip bone mineral density in men less than 60 years of age: MINOS study.
    Szulc P; Joly-Pharaboz MO; Marchand F; Delmas PD
    Calcif Tissue Int; 2004 Apr; 74(4):322-9. PubMed ID: 15255068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased serum IGF-I and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism.
    Földes J; Lakatos P; Zsadányi J; Horváth C
    Eur J Endocrinol; 1997 Mar; 136(3):277-81. PubMed ID: 9100552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low transforming growth factor-beta1 serum levels in idiopathic male osteoporosis.
    Akinci B; Bayraktar F; Saklamaz A; Demir T; Yener S; Comlekci A; Ozcan MA; Kebapcilar L; Yuksel F; Yesil S
    J Endocrinol Invest; 2007 May; 30(5):350-5. PubMed ID: 17598964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.